Erratum: Knockdown of angiotensinogen by shRNA-mediated RNA interference inhibits human visceral preadipocytes differentiation (International Journal of Obesity (2010) 34 (157-164) DOI: 10.1038/ijo.2009.197);Knockdown of angiotensinogen by shRNA-mediated RNA interference inhibits human visceral preadipocytes differentiation

International Journal of Obesity

Volumn 34, Issue 1, 2010, Pages 157-164

  Ye, Z W ^a   Wu, X M ^a   Jiang, J G ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Angiotensinogen; Differentiation; Plasmid construction; Preadipocytes; RNA interference

Indexed keywords

ANGIOTENSINOGEN; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LIPID; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVITY; HUMAN; INTRAABDOMINAL FAT; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA VECTOR; ADIPOCYTE; CELL CULTURE; CYTOLOGY; GENETICS; INVERTED REPEAT; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANGIOTENSINOGEN; CELL DIFFERENTIATION; CELLS, CULTURED; GLYCEROLPHOSPHATE DEHYDROGENASE; HUMANS; INVERTED REPEAT SEQUENCES; LIPID METABOLISM; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 74249102685     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.168     Document Type: Erratum

References (46)

1. Beahm EK, Walton RL, Patrick Jr CW. Progress in adipose tissue construct development. Clin Plast Surg 2003; 30: 547-558.
2. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP. Visceral obesity and the heart. Int J Biochem Cell Biol 2008; 40: 821-836.
3. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res 2004; 59: 169-205.
4. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
5. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
6. Langstein HN, Robb GL. Reconstructive approaches in soft tissue sarcoma. Semin Surg Oncol 1999; 17: 52-65.
7. Gomillion CT, Burg KJL. Stem cells and adipose tissue engineering. Biomaterials 2006; 27: 6052-6063.
8. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.
9. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 1994; 135: 2030-2036.
10. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 2001; 142: 487-492.
11. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17: 555-560.
12. Jones BH, Standridge MK, Taylor JW, Moustäid N. Angiotensino-gen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997; 273: R236-R242.
13. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 1993; 91: 2058-2064.
14. Bader M, Peters J, Baltatu O, Müller DN, Luft FC, Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001; 79: 76-102.
15. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990; 66: 883-890.
16. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 22348-22357.
17. Belova LA. Angiotensin II-generating enzymes. Biochemistry (Mosc) 2000; 65: 1337-1345.
18. Ye ZW, Wu XM, Jiang JG. Expression changes of angiotensin II pathways and bioactive mediators during human preadipocytes-visceral differentiation. Metabolism 2009; 58: 1288-1296.
19. Tong Q Hotamisligil GS. Molecular mechanisms of adipocyte differentiation. Rev Endocr Metab Disord 2001; 2: 349-355.
20. Morrison RF, Farmer SR. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr 2000; 130: 3116S-3121S.
21. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
22. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002; 20: 446-448.
23. Reynolds A, Leake D, Boese Q Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
24. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3, research0034.
25. A T Method. Methods 2001; 25: 402-408.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
27. Raḿirez-Zacaŕias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992; 97: 493-497.
28. Tijsterman M, Ketting RF, Plasterk RH. The genetics of RNA silencing. Annu Rev Genet 2002; 36: 489-519.
29. Mello CC, Conte Jr D. Revealing the world of RNA interference. Nature 2004; 431: 338-342.
30. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742-9747.
31. Yang S, Tutton S, Pierce E, Yoon K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 2001; 21: 7807-7816.
32. Hebert CG, Valdes JJ, Bentley WE. Beyond silencing\-engineering applications of RNA interference and antisense technology for altering cellular phenotype. Curr Opin Biotechol 2008; 19: 500-505.
33. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811. (Pubitemid 28099681)
34. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 2003; 13: 329-330.
35. Rodriguez AM, Elabd C, Delteil F, Astier J, Vernochet C, Saint-Marc P et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun 2004; 315: 255-263.
36. Cowherd RM, Lyle RE, McGehee Jr RE. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 1999; 10: 3-10.
37. Lin FT, Lane MD. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 1992; 6: 533-544.
38. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994; 8: 1654-1663.
39. Ron D, Brasier AR, Habener JF. Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response. Mol Cell Endocrinol 1990; 74: C97-C104.
40. Ailhaud G, Fukamizu A, Massiera F, Negrel R, Saint-Marc P, Teboul M. Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes 2000; 24: S33-S35.
41. Schling P, Löffler G. Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes. Horm Metab Res 2001; 33: 189-195.
42. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51: 1699-1707.
43. Saiki A, Koide N, Watanabe F, Murano T, Miyashita Y, Shirai K. Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system. Metabolism 2008; 57: 1093-1100.
44. Cook JR, Kozak LP. Sn-glycerol-3-phosphate dehydrogenase gene expression during mouse adipocyte development in vivo. Dev Biol 1982; 92: 440-448.
45. Ryall RL, Goldrick RB. Glycerokinase in human adipose tissue. Lipids 1977; 12: 272-277.
46. Swierczynski J, Zabrocka L, Goyke E, Raczynska S, Adamonis W, Sledzinski Z. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Mol Cell Biochem 2003; 254: 55-59.